Atlas Trials

Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients

Clinical trial NCT03038282 · UNKNOWN

Trial details

NCT number
NCT03038282
Sponsor
Metabolic Therapy Inc.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2017-02-20
Primary completion
2019-08-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.